Institute for Cell and Tissue Culture Technology, Department of Biotechnology, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria.
Cells. 2021 Apr 13;10(4):886. doi: 10.3390/cells10040886.
Mesenchymal stem cells (MSCs) are of great interest for their use in cell-based therapies due to their multipotent differentiation and immunomodulatory capacities. In consequence of limited numbers following their isolation from the donor tissue, MSCs require extensive expansion performed in traditional 2D cell culture setups to reach adequate amounts for therapeutic use. However, prolonged culture of MSCs in vitro has been shown to decrease their differentiation potential and alter their immunomodulatory properties. For that reason, preservation of these physiological characteristics of MSCs throughout their in vitro culture is essential for improving the efficiency of therapeutic and in vitro modeling applications. With this objective in mind, many studies already investigated certain parameters for enhancing current standard MSC culture protocols with regard to the effects of specific culture media components or culture conditions. Although there is a lot of diversity in the final therapeutic uses of the cells, the primary stage of standard isolation and expansion is imperative. Therefore, we want to review on approaches for optimizing standard MSC culture protocols during this essential primary step of in vitro expansion. The reviewed studies investigate and suggest improvements focused on culture media components (amino acids, ascorbic acid, glucose level, growth factors, lipids, platelet lysate, trace elements, serum, and xenogeneic components) as well as culture conditions and processes (hypoxia, cell seeding, and dissociation during passaging), in order to preserve the MSC phenotype and functionality during the primary phase of in vitro culture.
间充质干细胞(MSCs)因其多能分化和免疫调节能力而在基于细胞的治疗中受到广泛关注。由于从供体组织中分离出来后数量有限,因此需要在传统的 2D 细胞培养装置中进行广泛的扩增,以达到治疗用途所需的足够数量。然而,体外长时间培养 MSCs 已被证明会降低其分化潜力并改变其免疫调节特性。因此,为了提高治疗和体外建模应用的效率,在体外培养过程中保持 MSCs 的这些生理特性至关重要。有鉴于此,许多研究已经针对特定的培养基成分或培养条件的影响,对增强当前的 MSC 培养标准方案的某些参数进行了研究。尽管细胞的最终治疗用途有很多种,但标准分离和扩增的初始阶段是必不可少的。因此,我们想在体外扩增的这个基本初始阶段回顾一下优化标准 MSC 培养方案的方法。综述研究了针对培养基成分(氨基酸、抗坏血酸、葡萄糖水平、生长因子、脂质、血小板裂解液、微量元素、血清和异种成分)以及培养条件和过程(缺氧、细胞接种和传代时的分离)的改进措施,以在体外培养的初始阶段保持 MSC 表型和功能。